• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Rapid Design of Combination Antimicrobial Therapy against .针对……的联合抗菌疗法的快速设计
Comput Chem Eng. 2025 Jan;192. doi: 10.1016/j.compchemeng.2024.108884. Epub 2024 Sep 24.
2
Deciphering longitudinal optical-density measurements to guide clinical dosing regimen design: A model-based approach.解读纵向光密度测量值以指导临床给药方案设计:一种基于模型的方法。
Comput Methods Programs Biomed. 2022 Dec;227:107212. doi: 10.1016/j.cmpb.2022.107212. Epub 2022 Nov 1.
3
In vitro activities of ceftazidime/avibactam alone or in combination with antibiotics against multidrug-resistant Acinetobacter baumannii isolates.头孢他啶/阿维巴坦单独或联合抗生素对多重耐药鲍曼不动杆菌分离株的体外活性。
J Glob Antimicrob Resist. 2019 Jun;17:137-141. doi: 10.1016/j.jgar.2018.12.004. Epub 2018 Dec 18.
4
Quantitative assessment of combination antimicrobial therapy against multidrug-resistant Acinetobacter baumannii.针对多重耐药鲍曼不动杆菌的联合抗菌治疗的定量评估。
Antimicrob Agents Chemother. 2008 Aug;52(8):2898-904. doi: 10.1128/AAC.01309-07. Epub 2008 May 27.
5
Development of Modernized Acinetobacter baumannii Susceptibility Test Interpretive Criteria for Recommended Antimicrobial Agents Using Pharmacometric Approaches.应用药剂计量学方法制定推荐抗菌药物的改良鲍曼不动杆菌药敏试验解释标准。
Antimicrob Agents Chemother. 2023 Apr 18;67(4):e0145222. doi: 10.1128/aac.01452-22. Epub 2023 Mar 22.
6
Polymyxin B in combination with doripenem against heteroresistant Acinetobacter baumannii: pharmacodynamics of new dosing strategies.多黏菌素B联合多黏菌素E对异质性耐药鲍曼不动杆菌的作用:新给药策略的药效学研究
J Antimicrob Chemother. 2016 Nov;71(11):3148-3156. doi: 10.1093/jac/dkw293. Epub 2016 Aug 3.
7
Activity of Omadacycline Alone and in Combination against Carbapenem-Nonsusceptible Acinetobacter baumannii with Varying Minocycline Susceptibility.多黏菌素 E 联合或不联合美满霉素对不同米诺环素敏感性的碳青霉烯类药物耐药鲍曼不动杆菌的活性。
Microbiol Spectr. 2022 Jun 29;10(3):e0054222. doi: 10.1128/spectrum.00542-22. Epub 2022 Jun 1.
8
Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates.含头孢他啶-阿维巴坦的抗生素组合对广泛耐药铜绿假单胞菌的时间杀菌评估及其对头孢他啶-阿维巴坦耐药分离株的潜在作用。
Microbiol Spectr. 2021 Sep 3;9(1):e0058521. doi: 10.1128/Spectrum.00585-21. Epub 2021 Jul 28.
9
Using machine learning to optimize antibiotic combinations: dosing strategies for meropenem and polymyxin B against carbapenem-resistant Acinetobacter baumannii.利用机器学习优化抗生素组合:美罗培南和多粘菌素B对耐碳青霉烯鲍曼不动杆菌的给药策略
Clin Microbiol Infect. 2020 Sep;26(9):1207-1213. doi: 10.1016/j.cmi.2020.02.004. Epub 2020 Feb 12.
10
Pharmacodynamic modeling of aminoglycosides against Pseudomonas aeruginosa and Acinetobacter baumannii: identifying dosing regimens to suppress resistance development.氨基糖苷类药物对铜绿假单胞菌和鲍曼不动杆菌的药效学建模:确定抑制耐药性产生的给药方案。
Antimicrob Agents Chemother. 2008 Nov;52(11):3987-93. doi: 10.1128/AAC.01468-07. Epub 2008 Aug 25.

本文引用的文献

1
Rapid In Vitro Assessment of Antimicrobial Drug Effect Bridging Clinically Relevant Pharmacokinetics: A Comprehensive Methodology.抗菌药物疗效的快速体外评估与临床相关药代动力学的衔接:一种综合方法
Pharmaceutics. 2023 Jun 7;15(6):1671. doi: 10.3390/pharmaceutics15061671.
2
Modeling Heterogeneous Bacterial Populations Exposed to Antibiotics: The Logistic-Dynamics Case.模拟暴露于抗生素的异质细菌群体:逻辑动力学情况。
AIChE J. 2015 Aug;61(8):2385-2393. doi: 10.1002/aic.14882. Epub 2015 May 19.
3
Deciphering longitudinal optical-density measurements to guide clinical dosing regimen design: A model-based approach.解读纵向光密度测量值以指导临床给药方案设计:一种基于模型的方法。
Comput Methods Programs Biomed. 2022 Dec;227:107212. doi: 10.1016/j.cmpb.2022.107212. Epub 2022 Nov 1.
4
Discerning in vitro pharmacodynamics from OD measurements: A model-based approach.从光密度测量中识别体外药效学:一种基于模型的方法。
Comput Chem Eng. 2022 Feb;158. doi: 10.1016/j.compchemeng.2021.107617. Epub 2021 Dec 16.
5
Optimizing pharmacokinetics/pharmacodynamics of β-lactam/β-lactamase inhibitor combinations against high inocula of ESBL-producing bacteria.优化针对高浓度产 ESBL 细菌的β-内酰胺/β-内酰胺酶抑制剂组合的药代动力学/药效学。
J Antimicrob Chemother. 2021 Jan 1;76(1):179-183. doi: 10.1093/jac/dkaa412.
6
A robust LC-MS/MS method for amikacin: application to cellular uptake and pharmacokinetic studies.一种用于阿米卡星的稳健 LC-MS/MS 方法:在细胞摄取和药代动力学研究中的应用。
Bioanalysis. 2020 Apr;12(7):445-454. doi: 10.4155/bio-2020-0007. Epub 2020 Apr 28.
7
An Introduction to Terminology and Methodology of Chemical Synergy-Perspectives from Across Disciplines.化学协同作用的术语和方法导论——跨学科视角
Front Pharmacol. 2017 Apr 20;8:158. doi: 10.3389/fphar.2017.00158. eCollection 2017.
8
The drug-resistant bacteria that pose the greatest health threats.构成最大健康威胁的耐药细菌。
Nature. 2017 Feb 28;543(7643):15. doi: 10.1038/nature.2017.21550.
9
Determining β-lactam exposure threshold to suppress resistance development in Gram-negative bacteria.确定抑制革兰氏阴性菌耐药性产生的β-内酰胺暴露阈值。
J Antimicrob Chemother. 2017 May 1;72(5):1421-1428. doi: 10.1093/jac/dkx001.
10
Impact of empirical antimicrobial therapy on the outcome of critically ill patients with Acinetobacter bacteremia.经验性抗菌治疗对鲍曼不动杆菌血症重症患者预后的影响。
Ann Thorac Med. 2015 Oct-Dec;10(4):256-62. doi: 10.4103/1817-1737.164302.

针对……的联合抗菌疗法的快速设计

Rapid Design of Combination Antimicrobial Therapy against .

作者信息

Eales Brianna M, Smith James, Pouya Nazanin, Hudson Cole S, Tam Vincent H, Nikolaou Michael

机构信息

Department of Pharmacological and Pharmaceutical Sciences, University of Houston College of Pharmacy, Houston, TX 77204.

Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, TX 77204.

出版信息

Comput Chem Eng. 2025 Jan;192. doi: 10.1016/j.compchemeng.2024.108884. Epub 2024 Sep 24.

DOI:10.1016/j.compchemeng.2024.108884
PMID:39781207
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11709450/
Abstract

Treatment of serious bacterial infections with antimicrobial agents, such as antibiotics, is a major clinical challenge, because of growing bacterial resistance to multiple agents. Combination therapy (i.e. combined dosing of more than one agent) is often used for the purpose, but its systematic design remains a challenge. To address this, we recently reported a method to mathematically model bacterial response to antimicrobial agents, and to use this model for systematic design of clinically relevant combination therapy. The method relies on (a) longitudinal data of bacterial load, estimated from optical density measurements during time-kill experiments in an automated instrument, and (b) use of these data to fit a mathematical model for combination therapy design. In this work, we studied an application of the proposed method to (a) an important bacterial pathogen () and (b) two cases of antibiotic combinations (ceftazidime / amikacin and ceftazidime / avibactam) in synchronous and asynchronous dosing, not otherwise studied to date. Following the proposed method, optical density based data of bacterial load under antibiotic exposure for 20 h were used to calibrate the mathematical model and subsequently predict outcomes of various dosing regimens with clinically relevant pharmacokinetics. Representative predictions by the mathematical model were tested in a hollow fiber infection model over 120 h. Test outcomes validated these predictions. Collectively, this study both provides guidance for design of infection treatments with the agents studied and underscores the broader applicability of the proposed method for design of clinically relevant combination therapy.

摘要

使用抗生素等抗菌药物治疗严重细菌感染是一项重大临床挑战,因为细菌对多种药物的耐药性不断增强。联合治疗(即联合使用多种药物)常用于此目的,但其系统设计仍然是一个挑战。为了解决这个问题,我们最近报道了一种方法,通过数学模型来模拟细菌对抗菌药物的反应,并利用该模型进行临床相关联合治疗的系统设计。该方法依赖于:(a)在自动仪器的时间杀灭实验过程中,通过光密度测量估算出的细菌载量纵向数据;(b)利用这些数据来拟合联合治疗设计的数学模型。在这项工作中,我们研究了所提出方法在以下方面的应用:(a)一种重要的细菌病原体();(b)两种抗生素联合用药情况(头孢他啶/阿米卡星和头孢他啶/阿维巴坦),采用同步和异步给药方式,这些情况迄今尚未进行过其他研究。按照所提出的方法,利用抗生素暴露20小时后基于光密度的细菌载量数据来校准数学模型,并随后预测具有临床相关药代动力学的各种给药方案的结果。通过数学模型进行的代表性预测在中空纤维感染模型中进行了120小时的测试。测试结果验证了这些预测。总体而言,本研究既为所研究药物的感染治疗设计提供了指导,也强调了所提出方法在临床相关联合治疗设计方面更广泛的适用性。